Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE)
This study has been completed.
Study NCT00000464 Information provided by National Heart, Lung, and Blood Institute (NHLBI)
First Received: October 27, 1999 Last Updated: June 23, 2005
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Arrhythmia
Cardiovascular Diseases
Heart Arrest
Heart Diseases
Myocardial Infarction
Ventricular Fibrillation
Additional conditions recognized in this trial
Arrhythmias, Cardiac
Infarction
More general conditions related to this trial
Ischemia
Myocardial Ischemia
Necrosis
Pathologic Processes
Vascular Diseases
Interventions listed in this trial
amiodarone
imipramine
mexiletine
procainamide
propafenone
quinidine
sotalol
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic alpha-Antagonists
Adrenergic Antagonists
Adrenergic Uptake Inhibitors
Anti-Arrhythmia Agents
Anti-Infective Agents
Antidepressive Agents
Antidepressive Agents, Tricyclic
Antimalarials
Antiparasitic Agents
Antiprotozoal Agents
Cardiovascular Agents
Central Nervous System Agents
Cholinergic Agents
Cholinergic Antagonists
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Muscarinic Antagonists
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
National Heart, Lung, and Blood Institute (NHLBI)
Back to top of Main Content
